Pyxis Oncology Stock Forecast

Stock Price Forecast

According to 10 analysts polled by S&P Global, Pyxis Oncology stock has a consensus rating of "Strong Buy" and an average price target of $6.89. The average 1-year stock price forecast is 307.69% higher than the current stock price, while the lowest is $5.00 (+195.86%) and the highest is $9.00 (+432.54%).

Price Target: $6.89 (+307.69%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$6.89	$7.00	$9.00
Change	+195.86%	+307.69%	+314.20%	+432.54%

Analyst Ratings

The average analyst rating for Pyxis Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	7	7	7	7	7	8
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	9	9	9	9	9	10

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Sam Slutsky LifeSci Capital	LifeSci Capital	Buy Maintains $5 → $6	Buy	Maintains	$5 → $6	+255.03%	May 23, 2026
Robert Driscoll Wedbush	Wedbush	Buy Reiterates $6	Buy	Reiterates	$6	+255.03%	May 18, 2026
Leonid Timashev RBC Capital	RBC Capital	Buy Maintains $5	Buy	Maintains	$5	+195.86%	May 15, 2026
Unknown Analyst Guggenheim No rating	Guggenheim	Buy Maintains $7	Buy	Maintains	$7	+314.20%	May 15, 2026
Swayampakula Ramakanth H.C. Wainwright	H.C. Wainwright	Buy Reiterates $7	Buy	Reiterates	$7	+314.20%	May 15, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

38.89K

from 13.86M

-99.72%

from 13.86M

Revenue Next Year

2.78M

from 38.89K

7,042.66%

from 38.89K

EPS This Year

-1.23

from -1.28

EPS Next Year

-1.23

from -1.23

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	16.15M	13.86M	38.89K
Revenue Growth	-	-	-	-	-14.17%	-99.72%
Gross Profit	-	-	-	15.67M	11.47M	38.89K
Gross Margin	-	-	-	97.06%	82.77%	100.00%
Operating Income	-69.72M	-123.48M	-80.42M	-65.57M	-81.85M	-99.77M
Net Income	-75.98M	-120.72M	-73.79M	-77.33M	-79.62M	-92.76M
EPS	-	-	-	-	-1.28	-1.23
Free Cash Flow	-25.47M	-57.39M	-43.21M	-33.79M	-31.38M	-101.10M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	350,000
Avg	38,890
Low	n/a

Revenue Growth

Revenue Growth	2026	2027	2028
High	-97.5%
Avg	-99.7%
Low	-100.0%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-1.23
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-